Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer
Clinical trial NCT03887130 · COMPLETED
Trial details
- NCT number
- NCT03887130
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-27
- Primary completion
- 2013-04-18
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.